Michael Kindya, MD
Orthopaedic Surgery · Lauderdale Lakes, FLNPI 1548559834
Payments from drug & device makers
What this record shows
This record is dominated by education: $5,616 of the $7,477 with a category attached, or 75.1%. Southern Edge Orthopaedics, Inc. accounts for 75.1% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $2,151 and has fallen 95.8% since, to $91 in 2025.
Across 37 payments — averaging $202.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Southern Edge Orthopaedics, Inc.$6K
- Nalu Medical, Inc.$383
- Smith+Nephew$286
- Vericel Corporation$198
- Arthrex$174
- Stryker$164
- plus $656 from 9 others
What the payments were for
- Travel & lodging$1742%
- Food & beverage$1,68723%
- Education$5,61675%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Southern Edge Orthopaedics, Inc. | 6 | $5,616 |
| Nalu Medical, Inc. | 3 | $383 |
| Smith+Nephew | 6 | $286 |
| Vericel Corporation | 3 | $198 |
| Arthrex | 1 | $174 |
| Stryker | 2 | $164 |
| Biotissue Holdings Inc. | 4 | $157 |
| Pacira Pharmaceuticals Incorporated | 1 | $126 |
| Orthofix Medical, Inc. | 1 | $115 |
| Intuitive Surgical | 1 | $79 |
| Johnson & Johnson(2 entities) | 3 | $57 |
| Abbott | 2 | $49 |
| Mid-atlantic Surgical Systems, LLC | 2 | $42 |
| Boston Scientific | 1 | $17 |
| Bioventus LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Nalu Neurostimulation System$383
- Physio-Stim$230
- Regeneten$148
- MAKO$137
- MACI$130
- Iovera$126
- NEOX$104
- CLARIX$104
How this compares
$7,477 in reported general payments places this provider in the 55th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 283 | $4,388 |
| Ibuprofen | 90 | $479 |
| Methylprednisolone | 45 | $298 |
| Meloxicam | 155 | $254 |
| Celecoxib | 23 | $242 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 33 | $235 |
| Cyclobenzaprine Hcl | 50 | $175 |
| Gabapentin | 34 | $156 |
| Naproxen | 15 | $124 |
| Tramadol Hcl | 43 | $87 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Lauderdale Lakes
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Robert SantrockFernandina Beach$7.3M
- Martin RocheFt. Lauderdale$7.1M
- Steven LyonsTampa$6.7M
- Thomas BernasekTemple Terrace$6.4M
- Bryan SpringerJacksonville$6.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.